AMRX Insider Buying
The table below summarizes the most recent AMRX insider buying information — the latest buy being $44,000.00 by John Kiely on 5/19/2020, with links to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall Street, there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why AMRX insider buys like these are important for investors to follow.
| Date | Insider | Price | Amount |
|---|---|---|---|
| 5-19-2020 Insider Buy |
John Kiely Director |
$4.40 CAGR » |
$44,000.00 10,000 shares |
| 5-15-2020 Insider Buy |
Jeffrey P. George Director |
$4.16 CAGR » |
$99,049.60 23,810 shares |
| 3-4-2020 Insider Buy |
Chintu Patel Co-CEO and Director |
$3.90 CAGR » |
$974,941.89 250,000 shares |
| 3-4-2020 Insider Buy |
Chirag K. Patel President, Co-CEO & Director |
$3.90 CAGR » |
$974,958.01 250,000 shares |
| 3-1-2020 Insider Buy |
Joseph Todisco SVP, Specialty Commercial |
$3.62 CAGR » |
$144,800.00 40,000 shares |
| 8-28-2019 Insider Buy |
Ted C. Nark Director |
$2.39 CAGR » |
$119,500.00 50,000 shares |
| 8-16-2019 Insider Buy |
Pradeep Bhadauria SVP, Chief Scientific Officer |
$2.41 CAGR » |
$72,300.00 30,000 shares |
| 8-6-2019 Insider Buy |
International Ltd Fosun >10% Owner |
$2.91 CAGR » |
$951,570.00 327,000 shares |
| 8-7-2019 Insider Buy |
Andrew S. Boyer Exec VP, Comm Optns |
$2.89 CAGR » |
$192,664.74 66,666 shares |
| 8-5-2019 Insider Buy |
International Ltd Fosun >10% Owner |
$3.04 CAGR » |
$4,992,592.00 1,642,300 shares |
| 5-15-2019 Insider Buy |
Pradeep Bhadauria SVP, Chief Scientific Officer |
$8.48 CAGR » |
$59,360.00 7,000 shares |
| 5-13-2019 Insider Buy |
Andrew S. Boyer Exec VP, Comm Optns |
$9.46 CAGR » |
$179,740.00 19,000 shares |
| 5-13-2019 Insider Buy |
Joseph Todisco SVP, Specialty Commercial |
$9.88 CAGR » |
$148,200.00 15,000 shares |
| 3-12-2019 Insider Buy |
Robert A. Stewart President and CEO |
$11.92 CAGR » |
$202,640.00 17,000 shares |
| 3-12-2019 Insider Buy |
Paul Bisaro Executive Chairman |
$11.97 CAGR » |
$203,490.00 17,000 shares |
Also See: SEC filings
Amneal Pharmaceuticals Insider Purchase CAGR Analysis
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 05/20/2020 | |
| End date: | 09/04/2026 | |
| Start price/share: | $4.57 | |
| End price/share: | $17.44 | |
| Dividends collected/share: | $0.00 | |
| Total return: | 281.62% | |
| Average Annual Total Return: | 23.70% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $38,154.83 | |
| Years: | 6.30 | |
